Hydroxyurea marketed for sickle cell anemia.
D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000986:Antisickling Agents / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D014481:United States
D000986:Antisickling Agents; D006918:Hydroxyurea